Eikon Therapeutics, Inc. files its quarterly report, detailing financial metrics and operational updates that may impact the biological products industry.
| Name | Eikon Therapeutics, Inc. |
|---|---|
| CIK | 0001861123 |
| Tickers | EIKN |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 842807586 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 341-777-0566 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Eikon Therapeutics, Inc. files its quarterly report, detailing financial metrics and operational updates that may impact the biological products industry.
Eikon Therapeutics, Inc. announces its financial results for Q3 2026, showcasing clinical updates and ongoing growth in the biological products sector.
Eikon Therapeutics announces positive results from its EIK1001 trial for lung cancer, presented at the ESMO Congress, impacting the biological products sector.
Eikon Therapeutics shares promising clinical data from its PARP1 and WRN helicase programs at the European Society for Medical Oncology Congress.
69 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-456835 | 001-43085 | 261542956 | 34 | 10473931 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-456794 | 001-43085 | 261542905 | 34 | 295679 | 1 | 1 |
| 2026-10-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-430860 | 001-43085 | 261483365 | 34 | 210312 | 1 | 1 |
| 2026-10-23 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-429549 | 001-43085 | 261480110 | 34 | 258062 | 1 | 1 |
| 2026-10-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002331 | 005-95483 | 261446097 | 34 | 11566 | |||
| 2026-10-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-113112 | 005-95483 | 261434140 | 34 | 10108 | |||
| 2026-09-08 | 4 | 4 | 0001193125-26-385268 | 22303 | ||||||
| 2026-08-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-349936 | 001-43085 | 261275655 | 34 | 15826193 | 1 | 1 |
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-349185 | 001-43085 | 261273415 | 34 | 10018475 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-349154 | 001-43085 | 261273236 | 34 | 310216 | 1 | 1 |
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001987 | 005-95483 | 261246967 | 34 | 11557 | |||
| 2026-08-03 | 8-K | 8-K | 5.02 | 0001193125-26-330710 | 001-43085 | 261233704 | 34 | 144744 | 1 | 1 |
| 2026-06-15 | 3 | 3 | 0001193125-26-271167 | 19964 | ||||||
| 2026-06-10 | 8-K | 8-K | 5.02 | 0001193125-26-265861 | 001-43085 | 261079846 | 34 | 153122 | 1 | 1 |
| 2026-06-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-249725 | 001-43085 | 261047171 | 34 | 22097062 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001720215-26-000006 | 005-95483 | 26987944 | 34 | 20181 | |||
| 2026-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-221988 | 005-95483 | 26974698 | 34 | 6953 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-216791 | 001-43085 | 26963357 | 34 | 11333839 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-216744 | 001-43085 | 26963136 | 34 | 16102480 | 1 | 1 |
| 2026-05-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001183 | 005-95483 | 26946680 | 34 | 11067 | |||
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-000458 | 005-95483 | 26916022 | 34 | 10791 | |||
| 2026-03-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-130449 | 001-43085 | 26810034 | 34 | 186832 | 1 | 1 |
| 2026-03-30 | 10-K | 10-K | 0001193125-26-130395 | 001-43085 | 26809950 | 34 | 53083727 | |||
| 2026-03-04 | 4 | 4 | 0001193125-26-091798 | 5257 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091787 | 5222 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091783 | 5220 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091779 | 5342 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091771 | 5301 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091770 | 5274 | ||||||
| 2026-03-04 | 4 | 4 | 0001193125-26-091767 | 5261 | ||||||
| 2026-02-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001999371-26-003632 | 005-95483 | 26648522 | 34 | 15521 | |||
| 2026-02-12 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-049209 | 005-95483 | 26628156 | 34 | 140418 | |||
| 2026-02-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-013367 | 005-95483 | 26620783 | 34 | 28620 | |||
| 2026-02-10 | 4 | 4 | 0001193125-26-044903 | 9756 | ||||||
| 2026-02-09 | 4 | 4 | 0001193125-26-043320 | 49089 | ||||||
| 2026-02-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-011662 | 80155 | ||||||
| 2026-02-06 | 4 | 4 | 0001193125-26-041555 | 4319 | ||||||
| 2026-02-06 | 4 | 4 | 0001193125-26-041549 | 36127 | ||||||
| 2026-02-06 | 4 | 4 | 0001193125-26-041544 | 44920 | ||||||
| 2026-02-06 | S-8 | S-8 | 0001193125-26-041241 | 333-293272 | 26607983 | 33 | 246237 | 1 | 1 | |
| 2026-02-06 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-041201 | 001-43085 | 26607793 | 34 | 197149 | 1 | 1 |
| 2026-02-05 | 424B4 | 424B4 | 0001193125-26-039375 | 333-292633 | 26602881 | 33 | 14083739 | |||
| 2026-02-04 | 3 | 3 | 0001193125-26-038199 | 25318 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038168 | 39067 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038167 | 21783 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038164 | 20503 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038158 | 34949 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038147 | 17529 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038145 | 16092 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038139 | 23208 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038137 | 21978 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038136 | 20661 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038127 | 18970 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038125 | 7337 | ||||||
| 2026-02-04 | 3 | 3 | 0001193125-26-038115 | 27381 | ||||||
| 2026-02-04 | S-1MEF | S-1MEF | 0001193125-26-037993 | 333-293213 | 26599858 | 33 | 188513 | 1 | 1 | |
| 2026-02-04 | CERT | EIKN_8A_Cert_1861123.pdf | 0001354457-26-000137 | 001-43085 | 26597700 | 34 | 596428 | |||
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000406 | 333-292633 | 26585550 | 33 | 1734 | ||
| 2026-01-28 | 8-A12B | 8-A12B | 0001193125-26-026711 | 001-43085 | 26570363 | 34 | 14622 | |||
| 2026-01-28 | S-1/A | S-1/A | 0001193125-26-025565 | 333-292633 | 26568111 | 33 | 15406859 | 1 | 1 | |
| 2026-01-09 | S-1 | S-1 | 0001193125-26-008888 | 333-292633 | 26523031 | 33 | 19299068 | 1 | 1 | |
| 2025-12-12 | DRS/A | filename1.htm | 0001193125-25-317659 | 377-07990 | 251568646 | 33 | 14716012 | |||
| 2025-09-26 | DRS/A | filename1.htm | 0001193125-25-220186 | 377-07990 | 251349547 | 33 | 12581208 | |||
| 2025-07-01 | DRS/A | filename1.htm | 0000950123-25-006156 | 377-07990 | 251094003 | 33 | 12979564 | |||
| 2025-05-09 | DRS | filename1.htm | 0000950123-25-004458 | 377-07990 | 25929840 | 33 | 14199162 | |||
| 2025-02-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001861123-25-000001 | 021-539574 | 25689871 | 33 | 11239 | ||
| 2023-06-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001861123-23-000001 | 021-483121 | 23984309 | 33 | 15732 | ||
| 2022-01-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001861123-22-000001 | 021-428246 | 22515643 | 33 | 10376 | ||
| 2021-05-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001861123-21-000001 | 021-399311 | 21918869 | 33 | 8912 |
One latest value per concept from companyfacts (112 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 54.19M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 51.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 58.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.56B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 6.30M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 10.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | Assets | Assets | USD | 706.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 478.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 197,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 98.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 106.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -6.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 43.59 | 2025-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 11.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 54.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 54.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 2.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | Depreciation | Depreciation | USD | 15.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -5.43 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -5.43 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 20.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 53.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 5.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -7.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 5.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 13.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 11,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | LeaseDepositLiability | Lease Deposit Liability | USD | 6.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 530.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 39.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 35.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 36.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 38.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 10.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 281.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | Liabilities | Liabilities | USD | 321.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 706.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 66.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | LossContingencyAccrualCarryingValueCurrent | Loss Contingency, Accrual, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 363.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 83.83M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-216791 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 349.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -131.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -223.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -257.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -257.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 271.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -271.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 23.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 10.28M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 249.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 8.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 240.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 91.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.128 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 236,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 463,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 15.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | -99,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | PaymentsForProceedsFromTenantAllowance | Payments for (Proceeds from) Tenant Allowance | USD | 49.70M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349185 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 436.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 932,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 16.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 349.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 459,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 350.15M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 305.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -257.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 186.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 128.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 217.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 8.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 400,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 7.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.18B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 9.83M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 13.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 10.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 2.40M | 2025-04-02 | 2025-05-05 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 384.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 1.16B | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 3.75M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 158,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 1.16B | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 47.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 382 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 47.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456835 |